ARCHIVES

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

This article is from The Cancer Letter archive.

Vol. 09 No. 33 | August 19, 1983

Download PDF Visit The Full Archive

Related Articles

Award Fees Show House NCI thinks FCRF Contractors Are Performing

August 15, 1986

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979